{
    "organizations": [],
    "uuid": "805d494bc70aaf0309780eacda81b0b2a9a61d51",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-santhera-successfully-completes-fi/brief-santhera-successfully-completes-first-clinical-trial-with-omigapil-in-patients-with-congenital-muscular-dystrophy-idUSFWN1RH0OD",
    "ord_in_thread": 0,
    "title": "BRIEF-Santhera Successfully Completes First Clinical Trial With Omigapil In Patients With Congenital Muscular Dystrophy ‍​",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 5 (Reuters) - Santhera Pharmaceuticals Holding AG :\n* SUCCESSFUL COMPLETION OF FIRST CLINICAL TRIAL WITH OMIGAPIL IN PATIENTS WITH CONGENITAL MUSCULAR DYSTROPHY ‍​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-04-05T13:07:00.000+03:00",
    "crawled": "2018-04-06T21:57:24.009+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "santhera",
        "pharmaceutical",
        "holding",
        "ag",
        "successful",
        "completion",
        "first",
        "clinical",
        "trial",
        "omigapil",
        "patient",
        "congenital",
        "muscular",
        "dystrophy",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}